These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 226721)

  • 1. Labetalol binding to specific alpha- and beta-adrenergic sites in vitro and its antagonism of adrenergic responses in vivo.
    Greenslade FC; Tobia AJ; Madison SM; Krider KM; Newquist KL
    J Mol Cell Cardiol; 1979 Aug; 11(8):803-11. PubMed ID: 226721
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
    Aggerbeck M; Guellaen G; Hanoune J
    Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotensive effect of labetalol on intraocular pressure in rabbits: in relation to its alpha- and beta-adrenergic blocking action on the cardiovascular system.
    Kogure H; Hosaka A; Abiko Y
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):109-22. PubMed ID: 6268004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interaction of labetalol with alpha- and beta-adrenergic receptors : biochemical study (author's transl)].
    Dausse JP; Guicheney P; Maich PJ; Meyer P
    Nouv Presse Med; 1978 Oct; 7(35):3121-3. PubMed ID: 31601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Exogenous adrenergic stimulation by intravenous infusions of isoproterenol and blood levels of cyclic AMP before and after beta-blocking in humans].
    Nami R; Pizzuti M; Nardi PL; D'Ascenzo G; Maioli E; Gennari C
    Boll Soc Ital Cardiol; 1980; 25(7):763-8. PubMed ID: 6115658
    [No Abstract]   [Full Text] [Related]  

  • 6. Paradoxical inotropic effects of clonidine and labetalol in the conscious rabbit.
    McRitchie RJ; Chalmers JP
    J Cardiovasc Pharmacol; 1981; 3(4):818-27. PubMed ID: 6167811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamic and metabolic effects of combined adrenergic alpha- and beta-receptor blockade with labetalol in the exercising human forearm.
    Hartling OJ; Svendsen TL; Trap-Jensen J
    Eur J Clin Invest; 1980 Dec; 10(6):431-5. PubMed ID: 6265221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of labetalol in experimental animals.
    Baum T; Sybertz EJ
    Am J Med; 1983 Oct; 75(4A):15-23. PubMed ID: 6314811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol.
    Richards DA; Tuckman J; Prichard BN
    Br J Clin Pharmacol; 1976 Oct; 3(5):849-55. PubMed ID: 9968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
    Asano M; Hashimoto H; Nakashima M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular properties of medroxalol, a new antihypertensive drug.
    Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1981; 3(2):299-315. PubMed ID: 6166802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Labetalol in hypertension.
    Lancet; 1977 Apr; 1(8017):890-1. PubMed ID: 67294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of labetalol on the circulatory system (author's transl)].
    Monma Y; Okuoka Y; Kameda H; Ichihara K; Abiko Y; Tanabe T
    Nihon Yakurigaku Zasshi; 1980 May; 76(4):239-54. PubMed ID: 6108907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of alpha 1-adrenoceptors in guinea pig lung using 3H-prazosin.
    Barnes P; Karliner J; Hamilton C; Dollery C
    Life Sci; 1979 Oct; 25(14):1207-14. PubMed ID: 229373
    [No Abstract]   [Full Text] [Related]  

  • 16. A review of the haemodynamic effects of labetalol in man.
    Cohn JN; Mehta J; Francis GS
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):19S-26S. PubMed ID: 7093099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soterenol and related compounds: molecular modifications and changes in selectivity, affinity and efficacy at beta-adrenoreceptors in guinea-pig atria and trachea.
    Malta E; Raper C
    Clin Exp Pharmacol Physiol; 1977; 4(4):425-9. PubMed ID: 20258
    [No Abstract]   [Full Text] [Related]  

  • 18. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
    Riva E; Mennini T; Latini R
    Br J Pharmacol; 1991 Dec; 104(4):823-8. PubMed ID: 1687367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of 4-(2-hydroxy-3-[(1-methyl-3-phenylpropyl)amino]propoxy) benzeneacetamide (KF4317) and labetalol on alpha- and beta-adrenoceptors.
    Takayanagi I; Koike K; Konno F; Hiruta T; Kusunoki M; Sato T; Toyoda J; Kizawa Y
    Gen Pharmacol; 1986; 17(6):651-3. PubMed ID: 3028902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.